Home/Filings/4/0001567619-23-000574
4//SEC Filing

Ekman Lars 4

Accession 0001567619-23-000574

CIK 0001559053other

Filed

Jan 4, 7:00 PM ET

Accepted

Jan 5, 9:42 PM ET

Size

19.2 KB

Accession

0001567619-23-000574

Insider Transaction Report

Form 4
Period: 2023-01-03
Ekman Lars
Director
Transactions
  • Exercise/Conversion

    Ordinary Shares, par value $0.01 per share

    2023-01-03$6.41/sh+15,834$101,49616,077 total
  • Sale

    Ordinary Shares, par value $0.01 per share

    2023-01-03$55.35/sh2,897$160,3419,769 total
  • Sale

    Ordinary Shares, par value $0.01 per share

    2023-01-03$54.15/sh3,411$184,70712,666 total
  • Sale

    Ordinary Shares, par value $0.01 per share

    2023-01-03$56.98/sh1,303$74,2441,845 total
  • Sale

    Ordinary Shares, par value $0.01 per share

    2023-01-03$60.85/sh69$4,198243 total
  • Sale

    Ordinary Shares, par value $0.01 per share

    2023-01-03$56.33/sh6,621$372,9703,148 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2023-01-0315,8340 total
    Exercise: $6.41Exp: 2023-01-29Ordinary Shares (15,834 underlying)
  • Sale

    Ordinary Shares, par value $0.01 per share

    2023-01-03$58.67/sh1,523$89,353322 total
  • Sale

    Ordinary Shares, par value $0.01 per share

    2023-01-03$59.46/sh10$595312 total
Footnotes (8)
  • [F1]The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
  • [F2]The transaction was executed in multiple trades in prices ranging from $53.74 to $54.68, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in footnotes 2 through 7 of this Form 4.
  • [F3]The transaction was executed in multiple trades in prices ranging from $54.75 to $55.74, inclusive.
  • [F4]The transaction was executed in multiple trades in prices ranging from $55.76 to $56.755, inclusive.
  • [F5]The transaction was executed in multiple trades in prices ranging from $56.76 to $57.31, inclusive.
  • [F6]The transaction was executed in multiple trades in prices ranging from $58.195 to $58.92, inclusive.
  • [F7]The transaction was executed in multiple trades in prices ranging from $60.77 to $61.00, inclusive.
  • [F8]The option was granted on January 29, 2013, and all shares subject to the option were fully vested and exercisable January 29, 2014. The option would have expired in approximately one month and would have been forfeited to the extent it was not exercised on or prior to January 29, 2023.

Documents

1 file

Issuer

PROTHENA CORP PUBLIC LTD CO

CIK 0001559053

Entity typeother

Related Parties

1
  • filerCIK 0001376117

Filing Metadata

Form type
4
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 9:42 PM ET
Size
19.2 KB